Skip to main content
OpenTrials

Clinical trial condition

Psoriasis

Explore clinical trials studying Psoriasis. Study availability and eligibility vary by location and protocol.

933 public trials 73 recruiting studies
Refine in advanced search Browse all conditions

Psoriasis trial results

Completed

Immediate Response With Adalimumab and Its Impact on Quality of Life and Other Comorbidity Factors in Patients With Moderate to Severe Plaque Psoriasis

NCT01265823

Conditions
Psoriasis, Skin Diseases, Skin Diseases, Papulosquamous, +1 more
Locations
  • Site Reference ID/Investigator# 50942 Circuito Comercial Satelite, Mexico
  • Site Reference ID/Investigator# 40964 Iztapalapa, Mexico
  • Site Reference ID/Investigator# 50943 Mexico City, Mexico
  • Site Reference ID/Investigator# 40965 Monterrey, Mexico
View Trial Details
Completed

Efficacy Study of Dietary Intervention and Weight Loss in Improving Psoriasis

NCT01714284

Conditions
Psoriasis, Skin Diseases, Skin Diseases, Papulosquamous, +1 more
Locations
  • Department of Dermatology; Bellaria-Maggiore Hospital Bologna, Emilia-Romagna, Italy
  • Department of Dermatology; S.Orsola-Malpighi General Hospital Bologna, Emilia-Romagna, Italy
  • Dermatology Department; M. Bufalini Hospital Cesena, Emilia-Romagna, Italy
  • Department of Dermatology; S. Anna University Hospital Ferrara, Emilia-Romagna, Italy
View Trial Details
Completed

A Study of Safety and Efficacy Comparing ABT-874 Versus Methotrexate in Subjects With Moderate to Severe Plaque Psoriasis

NCT00679731

Conditions
Psoriasis, Skin Diseases, Skin Diseases, Papulosquamous, +1 more
Locations
  • Site Reference ID/Investigator# 9904 Graz, Austria
  • Site Reference ID/Investigator# 11001 Vienna, Austria
  • Site Reference ID/Investigator# 12763 Vienna, Austria
  • Site Reference ID/Investigator# 8022 Brussels, Belgium
View all 43 locations
View Trial Details
Completed

Efficacy and Safety of ABT-874 in Subjects With Moderate to Severe Chronic Plaque Psoriasis

NCT00292396

Conditions
Psoriasis, Skin Diseases, Skin Diseases, Papulosquamous, +1 more
Locations
  • Site Reference ID/Investigator# 3351 San Diego, California, United States
  • Site Reference ID/Investigator# 3347 Alpharetta, Georgia, United States
  • Site Reference ID/Investigator# 3348 Skokie, Illinois, United States
  • Site Reference ID/Investigator# 993 Indianapolis, Indiana, United States
View all 24 locations
View Trial Details
Completed

Effectiveness and Safety of 3 Dosing Regimens of CP-690,550 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis

NCT00678210

Conditions
Psoriasis, Skin Diseases, Skin Diseases, Papulosquamous, +1 more
Locations
  • Pfizer Investigational Site Tucson, Arizona, United States
  • Pfizer Investigational Site Little Rock, Arkansas, United States
  • Pfizer Investigational Site Oceanside, California, United States
  • Pfizer Investigational Site Jacksonville, Florida, United States
View all 44 locations
View Trial Details

Related conditions